Product category:
Analysis, simulation and mathematical software
News Release from: IDBS | Subject: ActivityBase
Edited by the Manufacturingtalk Editorial
Team on 13 July 2004
Ionix Pharmaceuticals Increases
Efficiency
Ionix Pharmaceuticals Increases Efficiency with ActivityBase from IDBS
IDBS, provider of integrated data management, analysis and decision-making software for biopharmaceutical discovery research, announced today that Ionix Pharmaceuticals Ltd of Cambridge, UK, has implemented IDBS' ActivityBase suite Ionix Pharmaceuticals is a leading research-based drug discovery organisation focusing on the discovery of novel analgesics for treatment of acute and chronic pain conditions
This article was originally published on Manufacturingtalk on 28 Jul 2004 at 8.00am (UK)
Related stories
Cancer Research Technology chooses ActivityBase
Cancer Research Technology Ltd expands drug discovery infrastructure - ActivityBase chosen for data management
IDBS launches ActivityBase 5.3 and SARview 6.0
IDBS, provider of integrated data management, analysis and decision-making software for life sciences, today announced ActivityBase 5.3 and SARview 6.0.
Ionix Pharmaceuticals will deploy ActivityBase to capture, manage and integrate biological, chemical and inventory data.
The company has implemented the ActivityBase software suite to cover its work process from registration of novel molecules, compound management using the ActivityBase Inventory Management module (AIM), and entry and manipulation of data from screening and secondary assays.
Efficiency has been significantly enhanced by using the automation facilities of ActivityBase, which allow real-time screening data entry and analysis.
The integrated solution offered by ActivityBase provides a single repository of information for both chemists and biologists.
In addition, Ionix will use IDBS' ChemXtra data cartridge to facilitate development and integration of custom workflow management processes that are chemically-aware.
Dr Iain James, Director of Drug Discovery at Ionix Pharmaceuticals commented: "We are impressed by the potential capabilities of ActivityBase and look forward to working with IDBS on this project." Neil Kipling, IDBS' Chairman and CEO commented: "We are delighted to be helping Ionix Pharmaceuticals put in place an extensible and sustainable informatics platform encompassing chemistry, biology and inventory.".
• IDBS: contact details and other news
• Email this article to a colleague
• Register for the free Manufacturingtalk email newsletter
• Manufacturingtalk Home Page
Search the Pro-Talk network of sites
